This ADC product is composed of an anti-CD22 antibody conjuagated via a CL2E linker to SN-38 (CL2E-SN-38). It has demonstrated a response in Acute Lymphoblastic Leukemia, non-Hodgkin's lymphoma, ALL, Haematological malignancies treatment by a MOA (Mechanism of Action) of Inhibit Topoisomerase I and cause DNA damage.
Download resources about recombinant antibody development and antibody engineering to boost your research.
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
TAB-183-F(E) | Anti-Human CD22 Recombinant Antibody (TAB-183-F(E)) | FuncS, IF, Neut, ELISA, FC, IP, ICC | Fv - disulfide stabilized |
TAB-1714CL-F(E) | Mouse Anti-CD22 Recombinant Antibody; Fab Fragment (TAB-1714CL-F(E)) | ELISA, WB | Mouse Fab |
TAB-003LC-F(E) | Mouse Anti-Human CD22 Recombinant Antibody Fab Fragment | FC | |
TAB-004LC-F(E) | Anti-Human CD22 Recombinant Antibody Fab Fragment | FC | |
TAB-005LC-F(E) | Mouse Anti-CD22 Recombinant Antibody; Fab Fragment (TAB-005LC-F(E)) | FC | Mouse Fab |
There are currently no Customer reviews or questions for ADC-031LCT. Click the button above to contact us or submit your feedback about this product.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.